Core Evidence
Volume 12, 2017 - Issue
Open access
147
Views
5
CrossRef citations to date
0
Altmetric
Review
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy
Thomas Karagiannis1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, GreeceCorrespondence[email protected]
, Eleni Bekiari1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
& Apostolos Tsapas1 Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;2 Harris Manchester College, University of Oxford, Oxford, United Kingdom
Pages 1-10
|
Published online: 15 Mar 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.